SelectScience Interviews
Experts at AAIC 2026 discuss the changing Alzheimer’s care pathway
How new diagnostic approaches could help clinicians identify, triage, and monitor patients earlier and more effectively
How new diagnostic approaches could help clinicians identify, triage, and monitor patients earlier and more effectively
Advancing Alzheimer's disease research with innovative plasma Tau biomarkers and automated, high-throughput assay workflows
At AAIC 2026, Dr. Ashton Harper, Roche Diagnostics, discusses how pTau217 could help reshape Alzheimer’s testing across primary and secondary care
Innovations in diagnostics and lab advocacy